Citation Searches Can Be Powerful Tools In Combating Redundant Publication

Recently in The Scientist ("Vigilant Science Journal Editors Fight Redundancy," March 8, 1993, page 1), writer Paul McCarthy focused on a widespread and apparently growing concern among publishing professionals: the attempt by some scientists, as McCarthy put it, to "add heft to their c.v.'s" by getting two or more articles into print that are based on a single research finding. He made the point that today's highly competitive job market has exacerbated the ongoing duplicate publishing problem

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The article correctly pointed out that the problem is by no means a new one. This situation has existed for a long time; it can't simply be chalked off as a transient byproduct of a depressed job market, reduced grants, or the increasing number of scientific journals being published.

Actually, the problem of redundant publication--intentional and otherwise--has been plaguing the science community for more than a quarter-century, and its presence certainly has not been confined to the United States. Its prevalence in Great Britain, for example, was the subject of a classic 1964 study by John Martyn, then research director of the Association of Special Libraries and Information Bureaux. In Martyn's survey, 25 percent of U.K. scientists reported unwitting duplication of research already reported in the literature (J. Martyn, "Unintentional duplication of research," New Scientist, 377:388, 1964).

To me, the problem of redundant and even plagiaristic publication was evident back ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies